Details for: S100A11
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 122.47rCSI 94.36%PRS 3.68
-
CSI 112.24rCSI 98.7%PRS 2.94
-
CSI 111.91rCSI 100%PRS 4.67
-
CSI 110.41rCSI 85.6%PRS 3.88
-
CSI 100.58rCSI 84.31%PRS 4.9
-
CSI 93.01rCSI 85.81%PRS 4.12
-
CSI 91.54rCSI 88.12%PRS 4.21
-
CSI 90.49rCSI 90.31%PRS 3.45
-
CSI 83.54rCSI 87.16%PRS 4.17
-
CSI 81.82rCSI 94.61%PRS 2.95
-
CSI 81.77rCSI 100%PRS 3.57
-
CSI 81.44rCSI 67.51%PRS 3.81
-
CSI 79.74rCSI 68.74%PRS 6.76
-
CSI 77.77rCSI 100%PRS 4.31
-
CSI 77.62rCSI 80.4%PRS 4.79
-
CSI 77.1rCSI 62.64%PRS 4.28
-
CSI 76.36rCSI 97.93%PRS 4.71
-
CSI 74.44rCSI 92.71%PRS 5.98
-
CSI 72.97rCSI 95.62%PRS 5.72
-
CSI 72.37rCSI 87.41%PRS 4.73
-
CSI 69.94rCSI 87.92%PRS 6.28
-
CSI 67.16rCSI 100%PRS 4.06
-
CSI 66.46rCSI 77.08%PRS 6.12
-
CSI 64.31rCSI 99.38%PRS 3.82
-
CSI 62.4rCSI 65.22%PRS 4.33
-
CSI 59.71rCSI 90.09%PRS 4.01
-
CSI 59.3rCSI 62.11%PRS 3.8
-
CSI 58.88rCSI 89.93%PRS 7.17
-
CSI 58.25rCSI 61.89%PRS 7.29
-
CSI 57.93rCSI 51.42%PRS 4.08
-
CSI 56.79rCSI 81.84%PRS 6.61
-
CSI 56.63rCSI 82.94%PRS 4.85
-
CSI 56.26rCSI 83.41%PRS 42.33
-
CSI 56.26rCSI 90.18%PRS 13.37
-
CSI 56.09rCSI 100%PRS 7.09
-
CSI 55.53rCSI 81.43%PRS 5.36
-
CSI 54.81rCSI 93.9%PRS 5.46
-
CSI 54.8rCSI 52.83%PRS 2.04
-
CSI 54.51rCSI 50.73%PRS 4.06
-
CSI 54.28rCSI 45.31%PRS 13.25
-
CSI 52.11rCSI 85.82%PRS 4.72
-
CSI 51.41rCSI 97.06%PRS 5.1
-
CSI 48.93rCSI 100%PRS 8.37
-
CSI 48.23rCSI 45.57%PRS 4.26
-
CSI 48.09rCSI 93.53%PRS 4.16
-
CSI 47.46rCSI 35.15%PRS 3.83
-
CSI 47.29rCSI 73.35%PRS 6.47
-
CSI 44.72rCSI 95.19%PRS 6.63
-
CSI 44.45rCSI 68.3%PRS 5.89
-
CSI 43.89rCSI 54.08%PRS 13.64
-
CSI 43.64rCSI 99.47%PRS 4.29
-
CSI 43.05rCSI 29%PRS 4.96
-
CSI 42.73rCSI 50.19%PRS 4.94
-
CSI 42.1rCSI 61.68%PRS 24.67
-
CSI 41.84rCSI 66.08%PRS 4.09
-
CSI 41.25rCSI 56.39%PRS 4.62
-
CSI 41.19rCSI 74.45%PRS 11.7
-
CSI 41rCSI 65.12%PRS 5.34
-
CSI 39.27rCSI 74.24%PRS 9.2
-
CSI 38.56rCSI 62.48%PRS 4.14
-
CSI 38.5rCSI 51.48%PRS 4.46
-
CSI 37.7rCSI 68.49%PRS 6.24
-
CSI 36.98rCSI 59.64%PRS 6.63
-
CSI 36.84rCSI 82.29%PRS 4.61
-
CSI 36.68rCSI 100%PRS 8.32
-
CSI 34.8rCSI 30.13%PRS 4.53
-
CSI 34.45rCSI 81.76%PRS 5.49
-
CSI 34.39rCSI 62.56%PRS 19.6
-
CSI 33.81rCSI 48.98%PRS 6.01
-
CSI 33.79rCSI 26.28%PRS 5.88
-
CSI 33.43rCSI 96.71%PRS 9.15
-
CSI 32.65rCSI 45.22%PRS 5.88
-
CSI 30.71rCSI 21.44%PRS 4.31
-
CSI 30.58rCSI 41.61%PRS 6.27
-
CSI 30.29rCSI 17.89%PRS 5.71
-
CSI 30.05rCSI 66.14%PRS 4.47
-
CSI 28.52rCSI 54.44%PRS 10.02
-
CSI 28.09rCSI 42.96%PRS 6.68
-
CSI 27.89rCSI 66.62%PRS 6.61
-
CSI 27.73rCSI 37.07%PRS 5.56
-
CSI 27.63rCSI 80%PRS 4.62
-
CSI 27.44rCSI 46.95%PRS 8.92
-
CSI 27.42rCSI 21.77%PRS 7.28
-
CSI 27.22rCSI 41.81%PRS 4.74
-
CSI 26.99rCSI 64.89%PRS 6.35
-
CSI 25.69rCSI 86.87%PRS 7.03
-
CSI 25.36rCSI 50.56%PRS 7
-
CSI 25.01rCSI 99.96%PRS 9.1
-
CSI 24.99rCSI 30.42%PRS 5.16
-
CSI 24.15rCSI 63.59%PRS 7.97
-
CSI 23.82rCSI 54.47%PRS 3.96
-
CSI 23.74rCSI 66.78%PRS 6.01
-
CSI 23.72rCSI 32.42%PRS 4.51
-
CSI 23.38rCSI 56.1%PRS 7.76
-
CSI 23.36rCSI 54.46%PRS 10.85
-
CSI 23.32rCSI 81.83%PRS 7.41
-
CSI 22.69rCSI 24.31%PRS 3.76
-
CSI 22.02rCSI 16.65%PRS 5.73
-
CSI 21.49rCSI 38.79%PRS 12.46
-
CSI 21.2rCSI 23.22%PRS 4.74
-
CSI -46.9rCSI -34.8%PRS 6.1%
-
CSI -29.9rCSI -52.4%PRS 3.2%
-
CSI -19.5rCSI -17.1%PRS 5.5%
-
CSI -16.5rCSI -22.5%PRS 3.7%
-
CSI -14.3rCSI -12.0%PRS 6.9%
-
CSI -10.5rCSI -47.3%PRS 22.1%
-
CSI -6.8rCSI -5.9%PRS 4.6%
-
CSI -6.4rCSI -32.0%PRS 23.2%
-
CSI -6.1rCSI -6.0%PRS 18.0%
-
CSI -5.5rCSI -5.6%PRS 7.7%
-
CSI -4.8rCSI -9.5%PRS 11.9%
-
CSI -3.8rCSI -4.9%PRS 5.1%
-
CSI -3.1rCSI -5.3%PRS 3.1%
-
CSI -3.0rCSI -3.6%PRS 7.1%
-
CSI -2.9rCSI -2.6%PRS 3.6%
-
CSI -2.0rCSI -9.1%PRS 18.9%
-
CSI -1.5rCSI -1.4%PRS 6.4%
-
CSI -1.5rCSI -2.4%PRS 3.2%
-
CSI -1.3rCSI -25.0%PRS 33.9%
-
CSI -1.2rCSI -4.2%PRS 18.8%
-
CSI -0.8rCSI -4.2%PRS 19.3%
-
CSI -0.6rCSI -2.6%PRS 12.3%
-
CSI -0.6rCSI -1.8%PRS 7.0%
-
CSI 0.0rCSI 0.1%PRS 6.4%
-
CSI 0.3rCSI 4.3%PRS 57.9%
-
CSI 0.4rCSI 1.1%PRS 14.7%
-
CSI 0.4rCSI 8.3%PRS 35.4%
-
CSI 0.5rCSI 1.9%PRS 6.8%
-
CSI 0.5rCSI 3.0%PRS 6.4%
-
CSI 0.5rCSI 1.5%PRS 5.9%
-
CSI 0.6rCSI 13.4%PRS 26.3%
-
CSI 0.6rCSI 5.1%PRS 10.6%
-
CSI 0.6rCSI 3.2%PRS 8.3%
-
CSI 0.7rCSI 6.5%PRS 44.4%
-
CSI 0.7rCSI 2.1%PRS 11.1%
-
CSI 0.8rCSI 2.2%PRS 4.7%
-
CSI 0.8rCSI 1.0%PRS 6.6%
-
CSI 0.9rCSI 23.9%PRS 22.8%
-
CSI 1.0rCSI 7.3%PRS 44.3%
-
CSI 1.1rCSI 11.6%PRS 6.9%
-
CSI 1.2rCSI 8.7%PRS 15.5%
-
CSI 1.3rCSI 11.2%PRS 25.6%
-
CSI 1.4rCSI 27.6%PRS 69.9%
-
CSI 1.4rCSI 5.0%PRS 13.3%
-
CSI 1.5rCSI 1.9%PRS 6.2%
-
CSI 1.6rCSI 17.0%PRS 28.3%
-
CSI 1.6rCSI 39.2%PRS 36.3%
-
CSI 1.7rCSI 50.0%PRS 10.0%
-
CSI 1.7rCSI 37.8%PRS 23.5%
-
CSI 1.8rCSI 8.4%PRS 7.0%
-
CSI 1.8rCSI 11.5%PRS 11.1%
-
CSI 2.0rCSI 1.5%PRS 6.9%
-
CSI 2.0rCSI 2.7%PRS 7.8%
-
CSI 2.1rCSI 10.3%PRS 5.4%
-
CSI 2.1rCSI 33.6%PRS 63.1%
-
CSI 2.4rCSI 38.5%PRS 41.5%
-
CSI 2.4rCSI 5.9%PRS 29.2%
-
CSI 2.5rCSI 5.9%PRS 10.0%
-
CSI 2.6rCSI 8.4%PRS 12.8%
-
CSI 2.6rCSI 40.4%PRS 10.8%
-
CSI 2.7rCSI 15.3%PRS 6.4%
-
CSI 2.7rCSI 62.8%PRS 30.2%
-
CSI 2.8rCSI 32.2%PRS 18.1%
-
CSI 2.8rCSI 2.2%PRS 4.9%
-
CSI 2.9rCSI 56.8%PRS 15.0%
-
CSI 3.0rCSI 9.7%PRS 6.6%
-
CSI 3.0rCSI 28.7%PRS 18.4%
-
CSI 3.1rCSI 3.0%PRS 12.3%
-
CSI 3.1rCSI 18.5%PRS 8.5%
-
CSI 3.2rCSI 16.4%PRS 8.2%
-
CSI 3.2rCSI 51.0%PRS 27.2%
-
CSI 3.3rCSI 8.5%PRS 4.9%
-
CSI 3.3rCSI 9.4%PRS 5.6%
-
CSI 3.4rCSI 13.1%PRS 4.5%
-
CSI 3.6rCSI 9.5%PRS 7.0%
-
CSI 3.6rCSI 91.5%PRS 14.6%
-
CSI 3.7rCSI 19.9%PRS 10.6%
-
CSI 3.7rCSI 20.3%PRS 19.9%
-
CSI 3.7rCSI 33.0%PRS 36.5%
-
CSI 3.7rCSI 86.5%PRS 5.5%
-
CSI 3.7rCSI 55.7%PRS 13.8%
-
CSI 3.8rCSI 89.7%PRS 15.6%
-
CSI 3.8rCSI 16.6%PRS 8.0%
-
CSI 4.0rCSI 3.0%PRS 5.4%
-
CSI 4.0rCSI 21.6%PRS 10.4%
-
CSI 4.0rCSI 32.4%PRS 4.3%
-
CSI 4.0rCSI 2.9%PRS 5.6%
-
CSI 4.1rCSI 5.8%PRS 4.6%
-
CSI 4.1rCSI 4.6%PRS 6.8%
-
CSI 4.1rCSI 54.8%PRS 14.4%
-
CSI 4.2rCSI 19.2%PRS 15.5%
-
CSI 4.2rCSI 42.9%PRS 37.2%
-
CSI 4.2rCSI 27.9%PRS 31.4%
-
CSI 4.3rCSI 12.2%PRS 7.9%
-
CSI 4.3rCSI 18.5%PRS 7.7%
-
CSI 4.4rCSI 8.4%PRS 9.4%
-
CSI 4.4rCSI 6.5%PRS 6.5%
-
CSI 4.4rCSI 76.9%PRS 17.3%
-
CSI 4.6rCSI 11.0%PRS 5.3%
-
CSI 4.7rCSI 12.5%PRS 4.2%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 1873279844
Symbol: S10AB_HUMAN
Name: Protein S100-A11
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 7889529
Title: Human calgizzarin; one colorectal cancer-related gene selected by a large scale random cDNA sequencing and northern blot analysis.
PubMed ID: 7889529
PubMed ID: 7490069
Title: Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17.
PubMed ID: 7490069
PubMed ID: 16710414
Title: The DNA sequence and biological annotation of human chromosome 1.
PubMed ID: 16710414
DOI: 10.1038/nature04727
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 1286667
Title: Microsequences of 145 proteins recorded in the two-dimensional gel protein database of normal human epidermal keratinocytes.
PubMed ID: 1286667
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19608861
Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.
PubMed ID: 19608861
PubMed ID: 20068231
Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
PubMed ID: 20068231
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 22814378
Title: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.
PubMed ID: 22814378
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
PubMed ID: 25944712
Title: N-terminome analysis of the human mitochondrial proteome.
PubMed ID: 25944712
PubMed ID: 18618420
Title: The structure of S100A11 fragment explains a local structural change induced by phosphorylation.
PubMed ID: 18618420
DOI: 10.1002/psc.1050
Sequence Information:
- Length: 105
- Mass: 11740
- Checksum: 1729ED680290CFE4
- Sequence:
MAKISSPTET ERCIESLIAV FQKYAGKDGY NYTLSKTEFL SFMNTELAAF TKNQKDPGVL DRMMKKLDTN SDGQLDFSEF LNLIGGLAMA CHDSFLKAVP SQKRT